INC Research, a global Phase I to IV contract research organization, announced an expanded relationship with the Society for Clinical Research Sites (SCRS) to become the society’s first Circle of Sustainability Sponsor. Through this enhanced relationship, INC Research will be the first organization to support SCRS’ new member Scholarship Program as well as the first CRO to establish a Site Advocacy Group (SAG). INC Research also will continue as a Global Impact Partner and Site Appreciation Reception sponsor for all SCRS’ Site Solutions Summit events globally across 2015.
Through the expanded relationship, INC Research will be the first CRO to establish a SAG, a new concept currently in use by TransCelerate BioPharma and Eli Lilly to facilitate ongoing dialogue with clinical investigators and site professionals worldwide in an effort to improve and drive efficiencies across the clinical development process. Through this approach, INC and investigative sites globally will exchange perspectives and insights on innovative methods, tools and technologies to enhance clinical research efficiency and more closely align the work of the sites and industry across the research ecosystem.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.